ILI Insider Trading Activity and SEC Form 4 Filings
ILI insider trading summary
No open-market insider purchases or sales of Interleukin Genetics Inc (ILI) have been reported on SEC Form 4 in the past 12 months.
Latest ILI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 24, 2008 | Lewis H Bender | Chief Executive Officer | Buy | $4K (15,400 @ $0.25) |
| Nov 24, 2008 | Lewis H Bender | Chief Executive Officer | Buy | $24 (100 @ $0.24) |
| Nov 24, 2008 | Eliot M Lurier | Chief Financial Officer | Buy | $3K (10,000 @ $0.29) |
| Nov 24, 2008 | Lewis H Bender | Chief Executive Officer | Buy | $1K (4,500 @ $0.25) |
| Nov 21, 2008 | Mary E Chowning | Director | Buy | $1K (5,000 @ $0.25) |
| Nov 21, 2008 | Lewis H Bender | Chief Executive Officer | Buy | $3K (10,000 @ $0.27) |
| Nov 21, 2008 | Mary E Chowning | Director | Buy | $1K (5,000 @ $0.27) |
| Nov 20, 2008 | Mary E Chowning | Director | Buy | $875 (2,500 @ $0.35) |
| Nov 20, 2008 | Lewis H Bender | Chief Executive Officer | Buy | $595 (1,700 @ $0.35) |
| Nov 20, 2008 | Lewis H Bender | Chief Executive Officer | Buy | $582 (1,765 @ $0.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.